Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

The effectiveness of intermittent bolus versus continuous infusion of neuromuscular blockade agents on ventilator free days in acute respiratory distress syndrome

EF 2023-24

Résumé
Hypoxemic respiratory failure (HRF) and its most severe subtype, acute respiratory distress syndrome (ARDS), are common in the intensive care unit (ICU) accounting for ~15% of admissions. Patients with ARDS require significant resources and have high rates of morbidity and mortality; up to 40% will not survive to hospital discharge. Neuromuscular blockade agents (NMBAs) are one example of a current therapy that can improve the outcomes of these patients. Evidence-based guidelines support a continuous intravenous infusion of NMBAs but this is associated with important risks. Intermittent bolus dosing of NMBAs, instead of continuous infusion, might offer the same benefits but with less harm. We will evaluate the association between the method of NMBA administration (intermittent bolus vs continuous infusion) and 1) patient and 2) healthcare utilization outcomes. This retrospective cohort study will analyze mechanically ventilated adults with HRF or ARDS in Alberta ICUs (2020-2022) who received any NMBAs. We will compare patients receiving an intermittent bolus vs continuous infusion of NMBA. The primary outcome is 28-day ventilator free days. Secondary outcomes are ICU and hospital mortality and length of stay. We will use mixed effects linear and logistic regression to evaluate the association between NMBA administration (bolus vs infusion) and outcomes. We will assess for effect modification and confounders, and stratify by sex to compare the proportions of females vs males receiving a bolus or infusion of NMBA. ARDS is a significant burden to patients and the healthcare system. Our findings comparing bolus to infusion NMBA will inform clinical practice, offer clarity for providers, provide rationale for future NMBA research, and may reduce the burden of ARDS.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
506406
Name
Knight Gwen
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The effectiveness of intermittent bolus versus continuous infusion of neuromuscular blockade agents on ventilator free days in acute respiratory distress syndrome
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Respiratory Distress Syndrome; Critical Care; Evidence-Based Practice; Intensive Care Units; Neuromuscular Blocking Agents
Abstract
Hypoxemic respiratory failure (HRF) and its most severe subtype, acute respiratory distress syndrome (ARDS), are common in the intensive care unit (ICU) accounting for ~15% of admissions. Patients with ARDS require significant resources and have high rates of morbidity and mortality; up to 40% will not survive to hospital discharge. Neuromuscular blockade agents (NMBAs) are one example of a current therapy that can improve the outcomes of these patients. Evidence-based guidelines support a continuous intravenous infusion of NMBAs but this is associated with important risks. Intermittent bolus dosing of NMBAs, instead of continuous infusion, might offer the same benefits but with less harm. We will evaluate the association between the method of NMBA administration (intermittent bolus vs continuous infusion) and 1) patient and 2) healthcare utilization outcomes. This retrospective cohort study will analyze mechanically ventilated adults with HRF or ARDS in Alberta ICUs (2020-2022) who received any NMBAs. We will compare patients receiving an intermittent bolus vs continuous infusion of NMBA. The primary outcome is 28-day ventilator free days. Secondary outcomes are ICU and hospital mortality and length of stay. We will use mixed effects linear and logistic regression to evaluate the association between NMBA administration (bolus vs infusion) and outcomes. We will assess for effect modification and confounders, and stratify by sex to compare the proportions of females vs males receiving a bolus or infusion of NMBA. ARDS is a significant burden to patients and the healthcare system. Our findings comparing bolus to infusion NMBA will inform clinical practice, offer clarity for providers, provide rationale for future NMBA research, and may reduce the burden of ARDS.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Knight, Gwen
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~